The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-3-(3-(4-Pentylphenyl)acrylamido)benzoic Acid ID: ALA4858374
PubChem CID: 164614216
Max Phase: Preclinical
Molecular Formula: C21H23NO3
Molecular Weight: 337.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCc1ccc(/C=C/C(=O)Nc2cccc(C(=O)O)c2)cc1
Standard InChI: InChI=1S/C21H23NO3/c1-2-3-4-6-16-9-11-17(12-10-16)13-14-20(23)22-19-8-5-7-18(15-19)21(24)25/h5,7-15H,2-4,6H2,1H3,(H,22,23)(H,24,25)/b14-13+
Standard InChI Key: XWCIZVNTJIEMGD-BUHFOSPRSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
4.6194 -2.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6181 -3.6481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3330 -4.0610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0494 -3.6477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0465 -2.8171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3312 -2.4080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7595 -2.4019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4754 -2.8118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1884 -2.3965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9044 -2.8063 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6173 -2.3912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1853 -1.5716 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3292 -2.8027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0416 -2.3883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0390 -1.5624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3180 -1.1528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6085 -1.5696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9034 -4.0601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1892 -3.6470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4745 -4.0590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7603 -3.6459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0456 -4.0577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7575 -2.7983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7602 -3.6233 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4706 -2.3835 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
9 12 2 0
11 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 11 1 0
2 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
14 23 1 0
23 24 1 0
23 25 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 337.42Molecular Weight (Monoisotopic): 337.1678AlogP: 4.77#Rotatable Bonds: 8Polar Surface Area: 66.40Molecular Species: ACIDHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.92CX Basic pKa: ┄CX LogP: 5.52CX LogD: 2.32Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.54Np Likeness Score: -0.44
References 1. Zhang H, Yu P, Lin H, Jin Z, Zhao S, Zhang Y, Xu Q, Jin H, Liu Z, Yang W, Zhang L.. (2021) The Discovery of Novel ACA Derivatives as Specific TRPM2 Inhibitors that Reduce Ischemic Injury Both In Vitro and In Vivo., 64 (7.0): [PMID:33784097 ] [10.1021/acs.jmedchem.0c02129 ]